APLNR inhibited nasopharyngeal carcinoma growth and immune escape by downregulating PD-L1.
Liu Y, Li N, Guo Y, Zhou Q, Yang Y, Lu J, Tian Z, Zhou J, Yan S, Li X, Shi L, Jiang S, Ge J, Feng R, Huang D, Zeng Z, Fan S, Xiong W, Li G, Zhang W.
Liu Y, et al. Among authors: lu j.
Int Immunopharmacol. 2024 Aug 20;137:112523. doi: 10.1016/j.intimp.2024.112523. Epub 2024 Jun 22.
Int Immunopharmacol. 2024.
PMID: 38909500